EAST WINDSOR, N.J. — Aurobindo Pharma announced the acquisition of a 239k sq.ft. manufacturing facility located in Caguas, Puerto Rico. The facility is designated for manufacturing oral solid dose products, both tablets and capsules, with both regular and high potency capabilities. Here some additional facility highlights below: